Modeling hypertrophic IP3 transients in the cardiac myocyte
- PMID: 17693463
- PMCID: PMC2072074
- DOI: 10.1529/biophysj.107.110031
Modeling hypertrophic IP3 transients in the cardiac myocyte
Abstract
Cardiac hypertrophy is a known risk factor for heart disease, and at the cellular level is caused by a complex interaction of signal transduction pathways. The IP3-calcineurin pathway plays an important role in stimulating the transcription factor NFAT which binds to DNA cooperatively with other hypertrophic transcription factors. Using available kinetic data, we construct a mathematical model of the IP3 signal production system after stimulation by a hypertrophic alpha-adrenergic agonist (endothelin-1) in the mouse atrial cardiac myocyte. We use a global sensitivity analysis to identify key controlling parameters with respect to the resultant IP3 transient, including the phosphorylation of cell-membrane receptors, the ligand strength and binding kinetics to precoupled (with G(alpha)GDP) receptor, and the kinetics associated with precoupling the receptors. We show that the kinetics associated with the receptor system contribute to the behavior of the system to a great extent, with precoupled receptors driving the response to extracellular ligand. Finally, by reparameterizing for a second hypertrophic alpha-adrenergic agonist, angiotensin-II, we show that differences in key receptor kinetic and membrane density parameters are sufficient to explain different observed IP3 transients in essentially the same pathway.
Figures
References
-
- Heineke, J., and J. D. Molkentin. 2006. Regulation of cardiac hypertrophy by intracellular signaling pathways. Nat. Rev. Mol. Cell Biol. 7:589–600. - PubMed
-
- Sugden, P. H. 1999. Signaling in myocardial hypertrophy: life after calcineurin? Circ. Res. 84:633–646. - PubMed
-
- Bare, D. J., C. S. Kettlun, M. Liang, D. M. Bers, and G. A. Mignery. 2005. Cardiac type 2 inositol 1,4,5-trisphosphate receptor: interaction and modulation by calcium/calmodulin-dependent protein kinase II. J. Biol. Chem. 280:15912–15920. - PubMed
-
- Hardt, S. E., and J. Sadoshima. 2002. Glycogen synthase kinase-3β: a novel regulator of cardiac hypertrophy and development. Circ. Res. 90:1055–1063. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
